The hybrid-DNA nanostructures could efficiently co-deliver the antigen peptide and CpG to CD8α+ DCs in the tumor-DLN, promoting potent antigen presentation to regulatory T cells via DC activation. The gene discussed is CD8A; the disease is neoplasm.